Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer
Clinical trial NCT03704688 · COMPLETED
Trial details
- NCT number
- NCT03704688
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2022-02-04
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.